‘Devastating effects’ caused by switching betweenbranded and generic Parkinson’s disease medication

摘要

Charity Parkinson's UK said patients had experienced pain and other symptoms afterbeing switched between branded and generic medications.Patients with Parkinson’s disease (PD) who had their medication switched because ofshortages have been detrimentally affected by the change, a leading UK charity has said. In a press release, published on 30 January 2023, Parkinson’s UK said patients had beenleft with “devastating effects” after being given prescriptions for a mixture of both Sinemet(Carbidopa/levodopa; Organon Pharma UK) and its generic version, co-careldopa; withsome patients not consulted about the change before it happened.